Radius Health (NASDAQ:RDUS) | WebDisclosure

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Radius Health

BRIEF

published on 07/31/2025 at 22:05, 4 months 4 days ago

Radius Pharmaceuticals Wins Patent Infringement Case

Legal Victory Patent Infringement Radius Pharmaceuticals Osteoporosis Treatment TYMLOS®
BRIEF

published on 07/31/2025 at 22:05, 4 months 4 days ago

Radius Pharmaceuticals remporte un procès pour violation de brevet

Victoire Juridique Violation De Brevet Radius Pharmaceuticals Traitement De L'ostéoporose TYMLOS®
PRESS RELEASE

published on 07/31/2025 at 22:00, 4 months 4 days ago

Radius Pharmaceuticals Announces Victory in Patent Infringement Case Against Orbicular Pharmaceutical Technologies for Osteoporosis Treatment TYMLOS(R)
Radius Pharmaceuticals and Ipsen Pharma win patent infringement suit against Orbicular Pharmaceutical Technologies for TYMLOS® generic for osteoporosis, upholding five patents validity until 2038

Osteoporosis TYMLOS Patent Infringement Radius Pharmaceuticals Radius Health
BRIEF

published on 01/02/2025 at 15:05, 11 months 2 days ago

Radius Pharmaceuticals Licenses Abaloparatide Rights to Pharmanovia for Asia Pacific Markets

Licensing Agreement Asia Pacific Abaloparatide Pharmanovia Osteoporosis Treatment
BRIEF

published on 01/02/2025 at 15:05, 11 months 2 days ago

Radius Pharmaceuticals accorde à Pharmanovia les droits sur l'abaloparatide pour les marchés de l'Asie-Pacifique

Asie-Pacifique Accord De Licence Abaloparatide Pharmanovia Traitement De L'ostéoporose
PRESS RELEASE

published on 01/02/2025 at 15:00, 11 months 2 days ago

Radius Pharmaceuticals Announces Licensing Agreement with Pharmanovia to Register and Commercialize Abaloparatide in China and Select Asia Pacific Territories
Radius Pharmaceuticals grants Pharmanovia exclusive commercialization rights to abaloparatide in Asia Pacific region for osteoporosis treatment, expanding global market presence

Asia Pacific Region Abaloparatide Radius Pharmaceuticals Pharmanovia Osteoporosis Treatment
BRIEF

published on 12/09/2024 at 16:15, 11 months 26 days ago

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement Globally

Global Market Expansion Radius Pharmaceuticals Theramex Agreement Osteoporosis Treatment ELADYNOS® Commercialization
BRIEF

published on 12/09/2024 at 16:15, 11 months 26 days ago

Radius Pharmaceuticals étend son accord de licence sur l'abaloparatide à l'échelle mondiale

Expansion Du Marché Mondial Radius Pharmaceutique Accord Avec Theramex Traitement De L'ostéoporose Commercialisation D'ELADYNOS®
PRESS RELEASE

published on 12/09/2024 at 16:10, 11 months 26 days ago

Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Radius Pharmaceuticals grants Theramex exclusive commercialization rights to ELADYNOS® for osteoporosis treatment in select regions, expanding global market access

Radius Pharmaceuticals Osteoporosis Treatment Theramex ELADYNOS Global Market Access

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 2 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 7 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 37 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 32 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 37 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 7 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 46 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 12 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 22 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 26 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:14, 12 hours 22 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 37 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 37 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 52 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 52 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE